Oral cannabidiol (CBD) as add-on to paracetamol for painful chronic osteoarthritis of the knee: a randomized, double-blind, placebo-controlled clinical trialResearch in context
Summary: Background: Painful knee osteoarthritis (KOA) is common, pharmacological treatment, however, is often hampered by limited tolerability. Cannabidiol, which preclinically showed anti-inflammatory, analgesic activity, could supplement established analgesics, but robust clinical trials are lack...
Saved in:
Main Authors: | Sibylle Pramhas (Author), Teresa Thalhammer (Author), Sebastian Terner (Author), Daniel Pickelsberger (Author), Andreas Gleiss (Author), Sabine Sator (Author), Hans G. Kress (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2023-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cannabinoids dosing for osteoarthritis-authors' reply
by: Sibylle Pramhas, et al.
Published: (2024) -
The use of cannabidiol (CBD) as an analgesic component
by: Kristian Kjær-Staal Petersen, et al.
Published: (2023) -
Towards Better Delivery of Cannabidiol (CBD)
by: Sophie Anne Millar, et al.
Published: (2020) -
The Anti-Inflammatory Effects of Cannabidiol (CBD) on Acne
by: Peyravian N, et al.
Published: (2022) -
Therapeutic Potential of Cannabidiol (CBD) for Skin Health and Disorders
by: Baswan SM, et al.
Published: (2020)